Predicting T‐cell quality during manufacturing through an artificial intelligence‐based integrative multiomics analytical platform
Open Access
- 16 December 2021
- journal article
- research article
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 7 (2) , e10282
Abstract
Large‐scale, reproducible manufacturing of therapeutic cells with consistently high quality is vital for translation to clinically effective and widely accessible cell therapies. However, the biological and logistical complexity of manufacturing a living product, including challenges associated with their inherent variability and uncertainties of process parameters, currently make it difficult to achieve predictable cell‐product quality. Using a degradable microscaffold‐based T‐cell process, we developed an artificial intelligence (AI)‐driven experimental‐computational platform to identify a set of critical process parameters and critical quality attributes from heterogeneous, high‐dimensional, time‐dependent multiomics data, measurable during early stages of manufacturing and predictive of end‐of‐manufacturing product quality. Sequential, design‐of‐experiment‐based studies, coupled with an agnostic machine‐learning framework, were used to extract feature combinations from early in‐culture media assessment that were highly predictive of the end‐product CD4/CD8 ratio and total live CD4+ and CD8+ naïve and central memory T cells (CD63L+CCR7+). Our results demonstrate a broadly applicable platform tool to predict end‐product quality and composition from early time point in‐process measurements during therapeutic cell manufacturing.Keywords
All Related Versions
Funding Information
- Division of Engineering Education and Centers (EEC‐1648035)
- Georgia Tech Foundation
This publication has 48 references indexed in Scilit:
- Paths to stemness: building the ultimate antitumour T cellNature Reviews Cancer, 2012
- Metabolic checkpoints in activated T cellsNature Immunology, 2012
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- A human memory T cell subset with stem cell–like propertiesNature Medicine, 2011
- Stimulating IL-13 Receptors on T cells: A New Pathway for Tolerance Induction in Diabetes?Diabetes, 2011
- Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1H NMR MetabonomicsAnalytical Chemistry, 2006
- Probing Latent Biomarker Signatures and in Vivo Pathway Activity in Experimental Disease States via Statistical Total Correlation Spectroscopy (STOCSY) of Biofluids: Application to HgCl2ToxicityJournal of Proteome Research, 2006
- Reverse signalling of membrane‐integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cellsImmunology, 2005
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995